These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17694590)

  • 21. Molecular insights into azumamide e histone deacetylases inhibitory activity.
    Maulucci N; Chini MG; Micco SD; Izzo I; Cafaro E; Russo A; Gallinari P; Paolini C; Nardi MC; Casapullo A; Riccio R; Bifulco G; Riccardis FD
    J Am Chem Soc; 2007 Mar; 129(10):3007-12. PubMed ID: 17311384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel histone deacetylase inhibitors: cyclic tetrapeptide with trifluoromethyl and pentafluoroethyl ketones.
    Jose B; Oniki Y; Kato T; Nishino N; Sumida Y; Yoshida M
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5343-6. PubMed ID: 15454224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, structural characterization and biological evaluation of N-protected cyclopropylethylcarbamates as potential histone deacetylase inhibitor.
    Jung JC; Moon HI; Oh S
    Chem Biol Drug Des; 2008 Dec; 72(6):592-5. PubMed ID: 19090926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AS1387392, a novel immunosuppressive cyclic tetrapeptide compound with inhibitory activity against mammalian histone deacetylase.
    Sasamura S; Sakamoto K; Takagaki S; Yamada T; Takase S; Mori H; Fujii T; Hino M; Hashimoto M
    J Antibiot (Tokyo); 2010 Nov; 63(11):633-6. PubMed ID: 20588300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total synthesis and full histone deacetylase inhibitory profiling of Azumamides A-E as well as β²- epi-Azumamide E and β³-epi-Azumamide E.
    Villadsen JS; Stephansen HM; Maolanon AR; Harris P; Olsen CA
    J Med Chem; 2013 Aug; 56(16):6512-20. PubMed ID: 23865683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FR235222, a fungal metabolite, is a novel immunosuppressant that inhibits mammalian histone deacetylase (HDAC) II. Biological activities in animal models.
    Mori H; Abe F; Furukawa S; Furukawa S; Sakai F; Hino M; Fujii T
    J Antibiot (Tokyo); 2003 Feb; 56(2):80-6. PubMed ID: 12715865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and campaign synthesis of pyridine-based histone deacetylase inhibitors.
    Andrews DM; Gibson KM; Graham MA; Matusiak ZS; Roberts CA; Stokes ES; Brady MC; Chresta CM
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2525-9. PubMed ID: 18378451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FR235222, a fungal metabolite, is a novel immunosuppressant that inhibits mammalian histone deacetylase III. Structure determination.
    Mori H; Urano Y; Kinoshita T; Yoshimura S; Takase S; Hino M
    J Antibiot (Tokyo); 2003 Feb; 56(2):181-5. PubMed ID: 12715880
    [No Abstract]   [Full Text] [Related]  

  • 29. Design, synthesis, and biological activity of boronic acid-based histone deacetylase inhibitors.
    Suzuki N; Suzuki T; Ota Y; Nakano T; Kurihara M; Okuda H; Yamori T; Tsumoto H; Nakagawa H; Miyata N
    J Med Chem; 2009 May; 52(9):2909-22. PubMed ID: 19419205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of thiols and glutathione conjugates of depsipeptide FK228 (FR901228), a novel histone protein deacetylase inhibitor, in the blood.
    Xiao JJ; Byrd J; Marcucci G; Grever M; Chan KK
    Rapid Commun Mass Spectrom; 2003; 17(8):757-66. PubMed ID: 12672127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and synthesis of thiazole-5-hydroxamic acids as novel histone deacetylase inhibitors.
    Anandan SK; Ward JS; Brokx RD; Denny T; Bray MR; Patel DV; Xiao XY
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5995-9. PubMed ID: 17827005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclic tetrapeptides with thioacetate tails or intramolecular disulfide bridge as potent inhibitors of histone deacetylases.
    Hoque MA; Arai T; Nishino N; Kim HJ; Ito A; Yoshida M
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6770-2. PubMed ID: 23021104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity relationships of aryloxyalkanoic acid hydroxyamides as potent inhibitors of histone deacetylase.
    Marson CM; Mahadevan T; Dines J; Sengmany S; Morrell JM; Alao JP; Joel SP; Vigushin DM; Charles Coombes R
    Bioorg Med Chem Lett; 2007 Jan; 17(1):136-41. PubMed ID: 17046252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vinyl ester-based cyclic peptide proteasome inhibitors.
    Baldisserotto A; Marastoni M; Fiorini S; Pretto L; Ferretti V; Gavioli R; Tomatis R
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1849-54. PubMed ID: 18294845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-activity relationship studies of novel oxygen-incorporated SAHA analogues.
    Kim SA; Jin YL; Kim HS
    Arch Pharm Res; 2009 Jan; 32(1):15-21. PubMed ID: 19183872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel amide derivatives as inhibitors of histone deacetylase: design, synthesis and SAR.
    Andrianov V; Gailite V; Lola D; Loza E; Semenikhina V; Kalvinsh I; Finn P; Petersen KD; Ritchie JW; Khan N; Tumber A; Collins LS; Vadlamudi SM; Björkling F; Sehested M
    Eur J Med Chem; 2009 Mar; 44(3):1067-85. PubMed ID: 18672316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2-Trifluoroacetylthiophenes, a novel series of potent and selective class II histone deacetylase inhibitors.
    Jones P; Bottomley MJ; Carfí A; Cecchetti O; Ferrigno F; Lo Surdo P; Ontoria JM; Rowley M; Scarpelli R; Schultz-Fademrecht C; Steinkühler C
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3456-61. PubMed ID: 18440229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and evaluation of novel organophosphorus inhibitors of bacterial ureases.
    Vassiliou S; Grabowiecka A; Kosikowska P; Yiotakis A; Kafarski P; Berlicki Ł
    J Med Chem; 2008 Sep; 51(18):5736-44. PubMed ID: 18717581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total synthesis and molecular target of largazole, a histone deacetylase inhibitor.
    Ying Y; Taori K; Kim H; Hong J; Luesch H
    J Am Chem Soc; 2008 Jul; 130(26):8455-9. PubMed ID: 18507379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and synthesis of phthalimide-type histone deacetylase inhibitors.
    Shinji C; Nakamura T; Maeda S; Yoshida M; Hashimoto Y; Miyachi H
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4427-31. PubMed ID: 16137884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.